Nayana Mudennavar

ORCID: 0000-0001-5264-6493 · 1 paper in corpus · active 2022

Study types

  • article 1
article 2022
·doi:10.3126/ajms.v13i10.45513

Background: Due to financial constraints, there are limited treatment options for Aplastic anemia (AA) in developing countries. Aims and Objectives: In the present observational retrospective study, utility of Cyclosporine A (CsA) along wit…